Solid-phase first antibody (SP), liquid-phase double-antibody (DA), and preprecipitated double-antibody (PPT) separation methods have been compared in a radioimmunoassay (RIA) for cortisol in unextracted serum. Both double-antibody methods gave values for pools close to target values assigned by gas chromatography-mass spectrometry (GeMS) whereas the SP assay had a significant negative bias, P <O'()()l (mean biases: SP -8 %, DA -2%, PPT -3 %). The SP and DA assays gave average values on patients' samples 12 %and 4 %lower than values by PPT.
The technique for separating antibody-bound from free antigen in radioimmunoassay (RIA) is important in determining the reliability of the assay, although frequently the choice of technique is made without reference to possible alternatives. Various separation techniques have been described for cortisol RIA, commonly (a) dextran-coated charcoal absorption, 1-3 (b) solid-phased antiserum linked to glass beads.! microcrystalline cellulose" 6 or coated plastic tubes," and (c) double-antibody precipitation techniques including, recently, a pre-precipitated double-antibody method. 8 All of these methods reportedly have good precision but the many variables in these assays, such as choice of antisera, tracer, and binding-protein inhibitors, do not allow conclusions to be drawn concerning the best choice of separation system.
The purpose of this study was to determine which separation method is most suitable for a nonextraction assay using sheep anti-cortisol-3-carboxymethyl oxime (anti-cortisol-3CMO) antisera and a cortisol-3CMO-1 25-I-iodohistamine (l25I-3-cortisol) label. We have compared the accuracy, precision, and sensitivity of the assay using (a) solid-phase separation using microcrystalline cellulose coupled first antibody (SP), (b) double-antibody separation with soluble antisera (DA), and (c) pre-precipitated double-antibody separation (PPT). 10 incubates. In the presence of CFS, there was a small (1-3 %) reduction in binding in all assay methods (Fig. 1 ). The reduction was constant at all concentrations, suggesting that the effect was not due to the presence of cortisol remaining in the CFS. Cortisol standards in CFS were therefore used in all further experiments. 1000 I a PRECISION Within-assay precision assessed by repeat analysis of medium pool gave coefficients of variation of SP 6·3% (mean 337 nmol/I, n = 25), DA 3·7 % (mean 378 nmol/l, n = 26), and PPT 3·9 % (mean 362 nrnol/l, n = 25).
The between-assay precision, assessed using the three serum pools and tri-level Ortho quality control material, is shown in Table 2 . The precision was significantly better in the PPT method when compared with SP and DA methods for the medium 
PRECISION PROFILE
Precision profiles for the PPT assay in routine use were calculated for patient samples assayed in duplicate as previously described.P
INTERFERENCE IN THE ASSAYS FROM SERUM
Calibration curves were prepared using calibrator solutions in diluent with either cortisol-free serum (CFS) (20 fl.1) or diluent (20 fl.1) added to the RIA
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RADIOIMMUNOASSAY REAGENTS,
CONDITIONS, AND PROCEDURES
Covalent coupling of the antiserum to cyanogen bromide-activated cellulose was accomplished by the method of Wide'' as modified by Seth et al. 5 The SP assay protocol was adapted from that described by Seth et~[.5 using a wash solution of 0·1 rnol/l saline containing 0·05% Triton X 100 (2 ml) before centrifugation.
In the DA assay, tracer and DAS were added as one reagent, and NSS and anticortisol serum were added as reagent 2 at dilutions which gave optimal precipitation and sensitivity.
Pre-precipitated double-antibody reagent (PPT) was prepared by mixing DAS, NSS, and anticortisol serum in optimal concentrations, leaving the reagent to precipitate at 4°C for at least 20 hours. The fine precipitate re-suspended on shaking and required no stirring during dispensing. The PPT reagent was stable when stored at 4°C for at least two months.
Assays were performed as detailed in Table 1 using fully optimised assay conditions. An incubation time of 1 hour at 37°C was chosen for the PPT assay, as there was no significant change in the calibration curve for incubation times between 1 and 3 hours at 37°C. All tubes were centrifuged at 1500 g for 30 minutes at 4°C, the supernatants were decanted, and pellets were counted for radioactivity in an NE 1600 gamma counter. pool, high pool, and high Ortho. The SP method was markedly less precise at low concentrations.
The PPT method has continued to give good precision in routine use (Table 2) , and the precision profile (mean ± SD) derived from seven assays, (Fig. 2) shows that the precision is adequate over tl e clinically important range. ACCURACY Pooled sera issued through the UK External Quality Assurance (UK EQA) scheme for steroid hormones (Tenovus Institute, Cardiff) were assayed by all three methods. Biases (mean ± SD) compared with GCMS target values for nine pools were: SP -8 % ± 3·5, DA -2% ± 4·2, and PPT -3% ± 5·4.
These biases ranged from -2 to -13~;'; in the SP assay, +10 to -12% for DA, and +4 to -17% for PPT. A paired t test showed that only the SP assay gave significantly different results from the GCMS values (p <0·001).
SENSITIVITY
The minimum detection limits, defined as the concentration of cortisol giving a depression of binding 2·5 x SD below that for Bo, were: 7·1, 9·5, and 9·5 nmol/l for SP, DA, and PPT methods. respectively. The mean precision profile (Fig. 2) for the PPT assay shows that the assay, in practice, is sufficiently precise at a lower limit of 50 nmol/l, NON-SPECIFIC BINDING (NSB) NSB values were determined for each method in 10 consecutive samples of medium pool and were found to be 1·4,2·5, and 3·2/~for SP, DA, and PPT methods respectively. 
RECOVERIES
Ten different patients' samples were assayed on at least three occasions before and after the addition of known amounts of cortisol. Values ranged from 10 to 600 nmol/l cortisol in the patients' samples, five of which then had 185 nmol/l and five 360 nmol/l cortisol added on a random basis. Recoveries (mean ± SD) were: SP 92·0 ± 8·5, DA 99·2 ± 8·3. and PPT 103· 1 ± 7·6 %.
ASSAYS ON PATIENTS' SAMPLES
Cortisol was measured in 50 patients' samples by the three RIA systems. Comparison of results from any two of these methods gave a correlation coefficient, r>0·96. The SP and DA assays gave on average values that were 12 and 4% lower than PPT, respectively. Mean values were: SP 367, DA 401, and PPT 418 nmol/l. The Wilcoxon matched pairs test showed that the three RIA methods gave results significantly different from each other (p<O·Ol). The requirements and general characteristics of separation techniques in radioimmunoassay have been reviewed previously.'! In this study we have compared the more reliable and convenient separation procedures of solid-phase first antibody separation (SP), double-antibody precipitation (DA), and a pre-precipitated double-antibody system (PPT) in an RIA for serum cortisol. Assay precision with either the DA or PPT antibody separation systems was superior to that of the SP system, despite the high slope of the calibration curve in the latter (Fig. 1) . The need to dispense reproducible quantities of solid-phase antibody from a stirred suspension may have contributed to the SP assay's imprecision. The finer suspension used in the PPT assay, however, does not require continual stirring during dispensing. Day-today variation in reagents is minimised here, since a batch of PPT reagent can be stored in aliquots for at least two months at 4°C.
The three assay systems investigated showed comparable minimum detection limits. The superior precision in the PPT assay offset the apparently less sensitive slope of the standard curve. The loss in sensitivity found in pre-precipitated double-antibody systems is thought to be due to masking of the binding sites on the first antibody by the anti-IgG. 12 Although liquid-phase double-antibody separation can be vulnerable to differences in the concentration of serum in the incubate.P a slight depression in antibody binding occurred with all three separation methods in the presence of antigen-free serum. This suggests that the non-specific serum effect occurs in the primary antigen-antibody reaction rather than at the separation stage.
Non-specific binding was acceptable in all assays but was lowest in the SP assay. This could be attributed to the saline wash step employed in the SP assay before centrifugation.
Data from the UK EQA scheme for steroid hormones suggest that both DA and PPT methods have satisfactory accuracy in relation to values determined by GCMS whereas the SP assay has a significant negative bias as judged by the paired t test. Consistent with these results on serum pools are the data from assays on patient samples which showed that PPT and DA assays gave values on average 12 % and 8 % higher than SP results, respectively. This difference appeared to be due to the SP assay recovering proportionately less cortisol than the DA and PPT assays, although the cause of th is effect is not clear.
Our results lead us to conclude that the conventional and pre-precipitated double-antibody methods are superior to the solid-phase assay in terms of precision and accuracy. The SP assay also has several practical disadvantages since the method requires the use of cyanogen bromide in the preparation of the solid-phase antiserum, the antiserum loses at least 50 %of its titre in the coupling process, and a wash stage is necessary for the attainment of acceptable NSB values.
Of the two double-antibody methods, the PPT method is preferable. This is partly because of its greater precision but mainly because of its practical convenience in that analysis within the working day is possible. This assay has now been in routine use in our laboratory for the past six months. During this time it has continued to produce accurate and precise results as judged from assay performance in internal QC and external QA. The pre-precipitated doubleantibody system therefore appears to offer a rapid and reliable method for separating bound from free ligand in the radioimmunoassay of serum cortisol. It may offer similar advantages in assays for other haptens,
